Lapatinib Herlapsa 250mg Tablet

Bottle of 250mg Tablet

4.5 (154)

₹5,000

Herlapsa 250mg Tablet is used to treat breast cancer, either alone or combined with other medications, and can help manage advanced-stage disease. It works by blocking HER2 and EGFR receptors responsible for excessive cell growth, stopping or slowing the multiplication of cancer cells. It should be taken on an empty stomach, either an hour before or two hours after a meal, exactly as prescribed, since correct dosing helps avoid serious side effects.

Description

Introduction Of Herlapsa 250mg Tablet:

Herlapsa 250mg Tablet is a targeted anti-cancer medicine used, in combination with other cancer medicines such as capecitabine, in the treatment of HER2-positive advanced or metastatic breast cancer.

Herlapsa 250mg Tablet should be taken on an empty stomach, at least one hour before or one hour after a meal, at the same time every day. Your doctor will decide what dose is necessary and how long you need to take it, depending on your medical condition and the other medicines it is combined with. You should take it exactly as your doctor has advised, and swallow the tablet whole with a glass of water without breaking, crushing, or chewing it. If you miss a dose, take it as soon as you remember, unless it is close to your next dose; do not double the dose.

Diarrhea and fatigue are among the most common effects of this medicine. Your doctor may advise regular monitoring of your heart function and liver enzymes while you are on treatment. Inform your doctor immediately if you notice upper stomach pain, itching, dark urine, pale stools, or yellowing of the skin or eyes, as this medicine can rarely cause serious liver toxicity.

Uses Of Herlapsa 250mg Tablet:

  • HER2-positive advanced or metastatic breast cancer

Benefits Of Herlapsa 250mg Tablet:

HER2-positive breast cancer

Some breast cancers grow because their cells produce an excess amount of a protein called human epidermal growth factor receptor 2 (HER2), which drives the growth and multiplication of cancer cells. Herlapsa 250mg Tablet works by inhibiting the excess production of this HER2 protein, which stops the uncontrolled growth of cancer cells and triggers their programmed cell death, helping control the disease in patients who have already received prior breast cancer treatment.

Side effects of Herlapsa 250mg Tablet:

Most side effects do not require any medical attention and disappear as your body adjusts to the medicine. Consult your doctor if they persist or if you’re worried about them.

Common side effects of Herlapsa:

  • Diarrhea
  • Fatigue
  • Nausea
  • Rash
  • Indigestion
  • Loss of appetite
  • Headache
  • Vomiting
  • Dry skin
  • Muscle pain (myalgia)

Mechanism Of Action Of Herlapsa 250mg Tablet:

Herlapsa Tablet contains Lapatinib, an anti-cancer medication that works against both the HER2 (human epidermal growth factor receptor 2) and EGFR (epidermal growth factor receptor) proteins, which are responsible for the excessive proliferation of cancer cells. By inhibiting these receptors, Herlapsa blocks the downstream signalling pathways that drive cancer cell growth, ultimately triggering the death of cancer cells.

Contact Us

Info Table
Packaging Size 30 Tablet
Composition LAPATINIB-250MG
Manufacturer/Marketer MYLAN PHARMACEUTICALS PVT LTD
Consume Type Oral
Treatment HER2-Positive Breast Cancer
Prescription/Non prescription Prescription
Form Tablet
Country of Origin Made in India
Vendor Info
Benefits
Reviews

Description

Introduction Of Herlapsa 250mg Tablet:

Herlapsa 250mg Tablet is a targeted anti-cancer medicine used, in combination with other cancer medicines such as capecitabine, in the treatment of HER2-positive advanced or metastatic breast cancer.

Herlapsa 250mg Tablet should be taken on an empty stomach, at least one hour before or one hour after a meal, at the same time every day. Your doctor will decide what dose is necessary and how long you need to take it, depending on your medical condition and the other medicines it is combined with. You should take it exactly as your doctor has advised, and swallow the tablet whole with a glass of water without breaking, crushing, or chewing it. If you miss a dose, take it as soon as you remember, unless it is close to your next dose; do not double the dose.

Diarrhea and fatigue are among the most common effects of this medicine. Your doctor may advise regular monitoring of your heart function and liver enzymes while you are on treatment. Inform your doctor immediately if you notice upper stomach pain, itching, dark urine, pale stools, or yellowing of the skin or eyes, as this medicine can rarely cause serious liver toxicity.

Uses Of Herlapsa 250mg Tablet:

  • HER2-positive advanced or metastatic breast cancer

Benefits Of Herlapsa 250mg Tablet:

HER2-positive breast cancer

Some breast cancers grow because their cells produce an excess amount of a protein called human epidermal growth factor receptor 2 (HER2), which drives the growth and multiplication of cancer cells. Herlapsa 250mg Tablet works by inhibiting the excess production of this HER2 protein, which stops the uncontrolled growth of cancer cells and triggers their programmed cell death, helping control the disease in patients who have already received prior breast cancer treatment.

Side effects of Herlapsa 250mg Tablet:

Most side effects do not require any medical attention and disappear as your body adjusts to the medicine. Consult your doctor if they persist or if you’re worried about them.

Common side effects of Herlapsa:

  • Diarrhea
  • Fatigue
  • Nausea
  • Rash
  • Indigestion
  • Loss of appetite
  • Headache
  • Vomiting
  • Dry skin
  • Muscle pain (myalgia)

Mechanism Of Action Of Herlapsa 250mg Tablet:

Herlapsa Tablet contains Lapatinib, an anti-cancer medication that works against both the HER2 (human epidermal growth factor receptor 2) and EGFR (epidermal growth factor receptor) proteins, which are responsible for the excessive proliferation of cancer cells. By inhibiting these receptors, Herlapsa blocks the downstream signalling pathways that drive cancer cell growth, ultimately triggering the death of cancer cells.

Contact Us

Reviews

There are no reviews yet.

Be the first to review “Lapatinib Herlapsa 250mg Tablet”

Your email address will not be published. Required fields are marked *

Frequently Asked Questions

From sourcing to delivery, we ensure reliability at every step. Our operations follow strict quality and regulatory standards.

What is Lapatinib Herlapsa 250mg Tablet used for?
Lapatinib Herlapsa 250mg Tablet is used to treat breast cancer, either alone or combined with other medications, including advanced-stage disease.
It blocks HER2 and EGFR receptors responsible for excessive cell growth, which stops or slows the multiplication of cancer cells.
It should be taken on an empty stomach, either an hour before or two hours after a meal, exactly as prescribed by your doctor.
It can help relieve symptoms of breast cancer such as breast lumps, unusual discharge from the nipples, or changes in the shape or texture of the breast.
Herlapsa 250mg Tablet is manufactured by Mylan Pharmaceutical Pvt. Ltd in India and contains Lapatinib 250mg, supplied as a bottle.
It works as a kinase inhibitor, blocking two proteins (HER2 and EGFR) that signal cancer cells to grow, and is used with other medications to treat HER2-positive breast cancer. See Drugs.com for more.

Related products